Monitoring mAb afucosylation using GlycINATOR

 

The level of core fucosylation on therapeutic antibodies have major impact on antibody dependent cell cytotoxicity. To study the core fucosylation, Suli Liu and Li Zang at Biogen have published a method using deglycosylation by GlycINATOR, reduction of the antibody and LC-MS analysis. Using this methodology the scientist could quantify the fucosylation within 1 h, including sample preparation and analysis. Liu and Zang argue that this methodology is particularly well suited for high-troughput analysis cell line development and process development of therapeutic mAbs.

 

Liu, S. & Zang, L., 2016. Rapid quantitation of monoclonal antibody N-glyco-occupancy and afucosylation using mass spectrometry. Analytical Biochemistry, pp.1–10.

 

 

Read more about GlycINATOR

 

Glycinator_Logo_Text_cmyk

Genovis and Promega sign global license agreement and settle litigation

Genovis has reached a settlement in its patent infringement lawsuit with Promega Corp. and agreed to a royalty bearing, worldwide license to the patents-in-suit.

The settlement ends all ongoing patent-infringement claims between the parties and Promega has agreed to a royalty bearing, worldwide license to the patents-in-suit, thereby ending the lawsuit between the parties. The specific terms of the contract are confidential.

“I am pleased we were able to reach a settlement with a favorable business solution that accommodates Genovis’ long term growth strategy,” says Fredrik Olsson, CEO of Genovis.

FabULOUS Fab Kit – Intact Fab fragments from mouse IgG

June 7, 2016 | Products |

FabFabKit

The FabULOUS (SpeB) enzyme digests IgG in the hinge region. The FabULOUS Fab kit is designed for digestion and purification of Fab fragments from mouse IgG antibodies. Incubation at optimized reducing conditions generates intact Fab, easily purified with spin columns.

  • Digestion in the hinge with FabULOUS
  • Affinity purification of Fab fragments using the light chain
  • Preparation of Fab fragments from mouse IgG in less than 2 h

Read more about FabULOUS Fab kit and order now

The Genovis team has published a review on FabRICATOR (IdeS) characterization of therapeutic antibodies

May 17, 2016 | References |

The Genovis team has together with Alain Beck, Senior Director Antibody Physico-Chemistry at Pierre Fabre, published a review article summarizing all the current publications using FabRICATOR (IdeS) for characterization of therapeutic antibodies and related products.

 

“The specificity and robustness of the IdeS digestion is critical for generating a homogenous pool of fragments. Combined with the limited sample preparation and ease of data interpretation, the IdeS enzyme has transformed antibody subunit analysis” Sjögren et al. 2016.

 

The review is published in The Analyst and demonstrates the wide use of FabRICATOR to study critical antibody qualities such as:

  • Fc-glycosylation
  • Oxidation
  • Drug antibody ratio on ADCs
  • Deamidation

The FabRICATOR enzyme specifically digests antibodies into F(ab’)2 and Fc/2 fragments that can be reduced to antibody subunits (Fd, LC and Fc/2) and studied with high mass accuracy.

 

Learn more on the FabRICATOR enzyme

 

Find the publication here

Screen Shot 2016-05-17 at 11.02.53

 

 

 

 

 

 

 

 

 

 

 

 

[New Reference] Using HILIC to study antibody subunits

Researchers at the University of Geneva led by Davy Guillarme has used a novel form of HPLC column, based on wide-pore hybrid silica bonded with amide ligand, and developed an HILIC analytical workflow for characterization of biopharmaceuticals. The scientists used FabRICATOR to fragment trastuzumab to subunits and studied the fragments using the new column with HILIC separation. The results showed that the method effectively separated important glycoforms of the Fc/2 fragment. The developed method is compatible with mass spectrometry, does not need high mobile phase temperatures, and allows serial coupling of columns.

Read more on this approach in Journal of Chromatography

More on the FabRICATOR enzyme

GingisREX – New Enzyme from Genovis

GingisRex_Logo_Gubbe

Genovis expands the protease portfolio with GingisREX – a new enzyme with unique specificity for arginine residues. The GingisREX protease can be used for peptide mapping, protein sequencing and post-translational modification analysis using mass spectrometry.

Press release

Read more about GingisREX

New references on IgG glycosylation, glycation and ADC characterization using IgGZERO and FabRICATOR

March 23, 2016 | References |

New references are out using Genovis enzymes to study antibody glycation, pairing of high-mannose glycans and ADC characterization using CE-MS.

Read more »

Genovis AB has signed a strategic cooperation agreement with Alphalyse A/S

The cooperation agreement will provide Genovis with access to Alphalyse’s expertise in mass spectrometry while Alphalyse will have the opportunity to offer its customers analyses based on Genovis’ unique enzymes for antibodies and other pharmaceutical proteins. Read more »

New reference of FabRICATOR in antibody based PET imaging

February 23, 2016 | References |

To develop an antibody based PET imaging for detection of amyloid beta in mouse models, Sehlin and colleagues  at the Rudbeck Laboratory in Uppsala, Sweden, used Fabricator to generate F(ab’)2 fragments. In the study, published in Nature Communications, Sehlin et al. generated F(ab’)2 fragments using FabRICATOR of an amyloid beta specific antibody and conjugated this to a transferrin receptor antibody for delivery across the blood brain barrier. Read more »

GingisKHAN_Banner_2560px

Genovis Launches New Enzyme Product

December 3, 2015 | Press Releases |

Genovis is launching a further development of GingisKHAN® that will be marketed under the name GingisKHAN®Fab kit. The product will be presented at the conference Antibody Engineering & Therapeutics in San Diego next week. Read more »